E3A Healthcare was invite to attend MOFCOM's Meeting for Foreign Invested Enterprises
On November 3rd, E3A Healthcare participated and delivered a speech in a roundtable meeting for foreign invested enterprises held by the Ministry of Commerce of the People’s Republic of China (MOFCOM) in Shanghai. This roundtable serves as a crucial platform for MOFCOM to actively listen to foreign invested enterprises' demands and enhance communication and collaboration with them.
Representatives from 12 foreign invested enterprises were invited to participate and speak at this roundtable. The meeting was moderated by Mr. Ling Qi, who serves as Vice Minister of Commerce and Deputy China International Trade Representative of the People's Republic of China. Governor Liang Huiling of Heilongjiang Province, Vice Governor Han Shengjian of Heilongjiang Province, Vice Governor Fang Wei of Jiangsu Province, and other pertinent leaders also attended the meeting.
At the meeting, Vice Minister Ling Ji said: “China is now comprehensively promoting Chinese modernization, unswervingly promoting high-level opening-up to the world, giving priority to attracting foreign investment, and continuously improving the business climate. China has a large market, a well-developed industrial system and abundant resources, and we sincerely welcome multinational enterprises to bring more high-quality products, technologies, and services to China and share in the development opportunities offered by the Chinese market. The Ministry of Commerce is committed to collaborating with relevant departments to enhance services and assurances for multinational companies and assist them in expanding their investment and cooperation in China.
Mr. Harry Chen, Partner and CFO of E3A Healthcare, shared the company's experience in developing the Chinese market and endorsed the Chinese government's efforts in attracting foreign investment and improving the business environment. E3A Healthcare remains committed to the Chinese market, and we are optimistic about the long-term development opportunities in China. We will continue to provide Chinese consumers with improved products and services for newborn and women’s health.
